We sought to examine the short - and long-term outcomes of patients who developed contrast-induced acute kidney injury ( CI-AKI ; defined as an increase in serum creatinine of 0.5 mg/dL or a 25 % relative rise within 48 h after contrast exposure ) from the large-scale HORIZONS-AMI trial .